Wallentin Medical Consulting ApS: Financial statements 2024
CVR: 41746505
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Wallentin Medical Consulting ApS (CVR 41746505) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 676,331 and a net result of DKK 517,283 compared with DKK 498,557 the year before. That is an increase of 3.3% compared with the year before. Equity in the 2024 report amounted to DKK 1,292,337. The solvency ratio was 82.7%.
- Gross Profit
- DKK 676,331
- Profit/Loss
- DKK 517,283
- Equity
- DKK 1,292,337
- Total Assets
- DKK 1,562,141
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 676K | 517K | 1.3M | - |
| 2023 | - | 655K | 499K | 897K | - |
| 2022 | - | 622K | 468K | 516K | - |
| 2021 | - | 1.2M | 953K | 1.4M | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Wallentin Medical Consulting ApS has published its annual report for 2023. Gross profit came to DKK 654,578, and the net result was DKK 498,557.
About Wallentin Medical Consulting ApS
Wallentin Medical Consulting ApS is a Danish company of the type Anpartsselskab based in Kolding, founded in 2020. The company is registered under the industry Alment praktiserende lægers aktiviteter. The management consists of Rikke Søjborg Wallentin. The company is owned by Rikke Søjborg Wallentin. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 684,736 and a net result of DKK 527,610 compared with DKK 517,283 the year before. Equity in the 2025 report amounted to DKK 1,684,947.
